Stay updated with breaking news from Silo Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Silo Pharma, Inc. (NASDAQ:SILO – Get Free Report) was the target of a large decline in short interest in the month of May. As of May 31st, there was short interest totalling 34,200 shares, a decline of 68.1% from the May 15th total of 107,200 shares. Approximately 1.0% of the shares of the company are […]
The study has identified a potentially new drug formulation that could potentially extend the period of remission and prevent relapse in patients with...
An experimental medication called CNM-Au8 — a drinkable liquid with gold nanocrystals — has shown promising results in clinical trials for improving MS symptoms. Doctors and researchers weighed in.
An experimental medication called CNM-Au8 — a drinkable liquid with gold nanocrystals — has shown promising results in clinical trials for improving MS symptoms. Doctors and researchers weighed in.
Shares of Silo Pharma, Inc. (SILO) are slipping over 13% on Wednesday morning after the company announced it is set to acquire exclusive licensing for a promising Alzheimer's disease therapy.